0      0

AONN+ Midyear 2022

FRI04 - Exelixis Clinical Product Overview for Advanced Practice Providers| Presentation by Exelixis

May 13, 2022 10:00am ‐ May 13, 2022 11:00am


This session provides a multi-indication overview of a treatment option in patients with Advanced Renal Cell Carcinoma (aRCC), Hepatocellular Carcinoma (HCC), or Differentiated Thyroid Cancer (DTC). The overview will include efficacy and safety data, dosing considerations, and adverse reaction management tips.


You must be logged in and own this session in order to post comments.